Analyst Reco. Kodiak Sciences Inc.

Equities

KOD

US50015M1099

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-08 pm EDT			5-day change	1st Jan Change
3.83 ^USD	-3.77%		+8.50%	+25.99%

May. 02	Kodiak Sciences Inc. Announces Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate Platform	CI
Apr. 04	UBS Adjusts Kodiak Sciences Price Target to $5 From $3, Maintains Neutral Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

UBS Adjusts Kodiak Sciences Price Target to $5 From $3, Maintains Neutral Rating	Apr. 04	MT
Barclays Raises Price Target on Kodiak Sciences to $3 From $2, Maintains Underweight Rating	Apr. 01	MT
UBS Trims Kodiak Sciences Price Target to $3 From $4, Maintains Neutral Rating	Dec. 21	MT
UBS Downgrades Kodiak Sciences to Neutral From Buy, Adjusts Price Target to $4 From $15	23-07-27	MT
Barclays Adjusts Price Target on Kodiak Sciences to $2 From $5, Maintains Underweight Rating	23-07-25	MT
Chardan Downgrades Kodiak Sciences to Neutral From Buy, Withdraws Price Target	23-07-25	MT
JPMorgan Downgrades Kodiak Sciences to Underweight From Neutral	23-07-25	MT
Capital One Downgrades Kodiak Sciences to Equalweight From Overweight, Adjusts Price Target to $7 From $24	23-07-24	MT
JPMorgan Chase Adjusts Price Target on Kodiak Sciences to $10 From $12, Maintains Neutral Rating	23-04-04	MT
Morgan Stanley Trims Price Target on Kodiak Sciences to $9 From $12, Maintains Equalweight Rating	22-11-14	MT
Goldman Sachs Adjusts Price Target on Kodiak Sciences to $8 From $9, Maintains Neutral Rating	22-11-10	MT
Morgan Stanley Adjusts Price Target on Kodiak Sciences to $12 From $10, Maintains Equalweight Rating	22-08-15	MT
Chardan Research Trims Kodiak Sciences' Price Target to $18 From $19, Reiterates Buy Rating	22-08-10	MT
Citigroup Raises Kodiak Sciences Price Target to $8 From $6, Sell Rating Reiterated	22-08-09	MT
Truist Securities Raises Kodiak Sciences Price Target to $15 From $10, Maintains Buy Rating	22-08-09	MT
Goldman Sachs Raises Kodiak Sciences Price Target to $9 From $5, Maintains Neutral Rating	22-08-09	MT
Citigroup Downgrades Kodiak Sciences to Sell From Neutral; Price Target is $6	22-08-02	MT
Berenberg Bank Terminates Coverage of 85 Companies in Consumer Discretionary, Healthcare, Industrial Tech, REIT, Software and IT Services Sectors	22-07-01	MT
Goldman Sachs Adjusts Price Target for Kodiak Sciences to $5 From $7, Reiterates Neutral Rating	22-05-24	MT
Morgan Stanley Lowers Kodiak Sciences' Price Target to $10 From $12, Maintains Equalweight Rating	22-05-17	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Kodiak Sciences Inc.

Equities

KOD

US50015M1099

Analyst Reco.

Filters